BioVex Inc.
Overview
BioVex Inc. is a biotechnology company specializing in the development of oncolytic virus therapies. It became a subsidiary of Amgen Inc. following its acquisition, allowing it to leverage additional resources and expertise in advancing its innovative treatments for cancer.
Therapeutic areas
OncologyVirology
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to BioVex Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.